A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
Condition:   Crohn's Disease Intervention:   Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2022 Category: Research Source Type: clinical trials

Efficacy of Ustekinumab-based Integrated Medicine Therapy in Patients With Symptomatic Stricturing Crohn's Disease
Conditions:   Crohn Disease;   Stricture; Bowel;   Intestinal Stricture Intervention:   Drug: Ustekinumab Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Sixth Affiliated Hospital, Sun Yat-sen University;   Second Affiliated Hospital of Soochow University;   Chongqing Renji Hospital, University of Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials